{
  "id": "mhgap#risk_safety_bf436dc7",
  "content": "tinuing the first.\n»\nIf response is still poor,\n– Review diagnosis.\n– REFER TO SPECIALIST.\n»\nFollow-up more frequently.\nCLINICAL TIP:\n»\nADVERSE EFFECTS (e.g. drowsiness, nystagmus, diplopia, ataxia)\nare from too high doses of medication for the person.\n»\nIf there is an IDIOSYNCRATIC REACTION (allergic reaction, bone\nmarrow depression, hepatic failure), switch antiepileptic medication.\nEPILEPSY 67\n68\nEPI 3\nEPILEPSY Follow-up\n2\nMONITOR TREATMENT\nAt every contact:\n» »\nEvaluate side-effects of medication including adverse effects Does the patient have any new symptoms of concern?\nand idiosyncratic reactions (clinically and with appropriate laboratory tests Review for any new symptoms of depression and anxiety given\nwhen available). high risk of co-morbidity with epilepsy.\n» »\nProvide psychoeducation and review psychosocial interventions. Is the patient on any new medications that may have interactions?\n» (Many anticonvulsants have interactions with other medications). If so,\nIs the person a woman of childbearing age and considering\nconsult a specialist.\npregnancy? If so, consult specialist.\n3\nCONSIDER MEDICATION DISCONTINUATION WHEN APPROPRIATE\nHas the person been convulsion free for several years?\n»\nD iscuss risk of seizure occurrence with person/carer",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "screening_cues",
      "referral",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety tinuing the first.\n»\nIf response is still poor,\n– Review diagnosis.\n– REFER TO SPECIALIST.\n»\nFollow-up more frequently.\nCLINICAL TIP:\n»\nADVERSE EFFECTS (e.g. drowsiness, nystagmus, diplopia, ataxia)\nare from too high doses of medication for the person.\n»\nIf there is an IDIOSYNCRATIC REACTION (allergic reaction, bone\nmarrow depression, hepatic failure), switch antiepileptic medication.\nEPILEPSY 67\n68\nEPI 3\nEPILEPSY Follow-up\n2\nMONITOR TREATMENT\nAt every contact:\n» »\nEvaluate side-effects of medication including adverse effects Does the patient have any new symptoms of concern?\nand idiosyncratic reactions (clinically and with appropriate laboratory tests Review for any new symptoms of depression and anxiety given\nwhen available). high risk of co-morbidity with epilepsy.\n» »\nProvide psychoeducation and review psychosocial interventions. Is the patient on any new medications that may have interactions?\n» (Many anticonvulsants have interactions with other medications). If so,\nIs the person a woman of childbearing age and considering\nconsult a specialist.\npregnancy? If so, consult specialist.\n3\nCONSIDER MEDICATION DISCONTINUATION WHEN APPROPRIATE\nHas the person been convulsion free for several years?\n»\nD iscuss risk of seizure occurrence with person/carer Tinuing the first. »\nif response is still poor,\n– review diagnosis."
}